Clinical Report: Risk Stratification of Patients with Dermal Leiomyosarcoma

Overview

This study investigates risk factors associated with dermal leiomyosarcoma (dLMS) metastasis and local recurrence using data from the Danish National Health Registers.

Background

Dermal leiomyosarcoma (dLMS) is a rare neoplasm with a notable risk of local recurrence but a generally low risk of metastasis. Accurate risk stratification is crucial for managing patient outcomes, yet existing classifications lack validation for dLMS.

Data Highlights

No numerical data or trial data provided in the source material.

Key Findings

• dLMS is classified as an intermediate-risk neoplasm with a risk of local recurrence.
• Metastasis rates for dLMS vary from 0% to 14% in previous studies.
• No significant difference in metastasis risk was found between AISMN and dLMS.
• Current AJCC staging is not validated for cutaneous sarcomas like dLMS.
• Risk factor studies for dLMS have been limited by small sample sizes and short follow-up periods.

Clinical Implications

The findings highlight the need for improved risk stratification methods for dLMS to guide clinical management. Further research is warranted to establish validated classifications that can inform treatment decisions and follow-up protocols.

Conclusion

This study underscores the complexity of risk assessment in dLMS and the necessity for further investigation into its metastatic potential and classification.

Related Resources & Content

1. Author(s)/Org, Source, Year -- Title
2. American Cancer Society, Soft Tissue Sarcomas -- https://www.cancer.org/cancer/types/soft-tissue-sarcoma.html
3. Pathologica, 2025 -- Classification/terminology and risk framing
4. the asco post — Spatial Transcriptomics Identifies Novel Subtypes Associated With Disease Prognosis in Leiomyosarcoma
5. Frontiers in Medicine — Integrating Machine Learning and Clinicopathological Data to Stratify Survival Risk in Young Women with Localized Breast Cancer
6. A novel nomogram utilizing log odds of positive lymph nodes to forecast overall survival in colorectal signet ring cell carcinoma patients: Insights from a SEER population-based analysis
7. Prognostic Significance of Sarcomatoid Component Proportion in Grade 4 Non-Metastatic Clear Cell Renal Carcinoma
8. Spatial Transcriptomics Identifies Novel Subtypes Associated With Disease Prognosis in Leiomyosarcoma
9. Integrating Machine Learning and Clinicopathological Data to Stratify Survival Risk in Young Women with Localized Breast Cancer
10. https://www.pathologica.it/article/download/694/485/5588
11. Soft Tissue Sarcomas | American Cancer Society
12. Prognosis and Follow‐Up Recommendations for Subcutaneous and Dermal Leiomyosarcoma: Local Recurrence, Metastasis, and Overall Survival in a Danish Nationwide Cohort of 661 Patients - PMC